Pacific Hospital Supply Co Ltd
Pacific Hospital Supply Co., Ltd., together with its subsidiaries, manufactures, processes, and sells medical disposable products and equipment in Taiwan. The company's disposable medical devices include tubings, bags, bottles, closed wound drainage systems, surgical suction instruments, respiratory therapy products, and other products. It also provides medical gas systems, such as medical gas ou… Read more
Pacific Hospital Supply Co Ltd (4126) - Net Assets
Latest net assets as of September 2025: NT$2.87 Billion TWD
Based on the latest financial reports, Pacific Hospital Supply Co Ltd (4126) has net assets worth NT$2.87 Billion TWD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$3.78 Billion) and total liabilities (NT$904.27 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$2.87 Billion |
| % of Total Assets | 76.07% |
| Annual Growth Rate | 6.81% |
| 5-Year Change | 12.55% |
| 10-Year Change | 45.49% |
| Growth Volatility | 5.57 |
Pacific Hospital Supply Co Ltd - Net Assets Trend (2009–2024)
This chart illustrates how Pacific Hospital Supply Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Pacific Hospital Supply Co Ltd (2009–2024)
The table below shows the annual net assets of Pacific Hospital Supply Co Ltd from 2009 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$2.94 Billion | +3.84% |
| 2023-12-31 | NT$2.83 Billion | +4.30% |
| 2022-12-31 | NT$2.72 Billion | +0.42% |
| 2021-12-31 | NT$2.71 Billion | +3.50% |
| 2020-12-31 | NT$2.61 Billion | +2.44% |
| 2019-12-31 | NT$2.55 Billion | +10.41% |
| 2018-12-31 | NT$2.31 Billion | +2.25% |
| 2017-12-31 | NT$2.26 Billion | +3.22% |
| 2016-12-31 | NT$2.19 Billion | +8.29% |
| 2015-12-31 | NT$2.02 Billion | +9.73% |
| 2014-12-31 | NT$1.84 Billion | +9.51% |
| 2013-12-31 | NT$1.68 Billion | +2.48% |
| 2012-12-31 | NT$1.64 Billion | +8.80% |
| 2011-12-31 | NT$1.51 Billion | +11.90% |
| 2010-12-31 | NT$1.35 Billion | +23.12% |
| 2009-12-31 | NT$1.10 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Pacific Hospital Supply Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 14569.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$1.35 Billion | 45.73% |
| Other Components | NT$1.60 Billion | 54.27% |
| Total Equity | NT$2.94 Billion | 100.00% |
Pacific Hospital Supply Co Ltd Competitors by Market Cap
The table below lists competitors of Pacific Hospital Supply Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sedlmayr Grund und Immobilien AG
F:SPB
|
$128.77 Million |
|
Eagle Financial Services Inc Common Stock
OTCQX:EFSI
|
$128.78 Million |
|
Chison Medical Technologies Co Ltd
SHG:688358
|
$128.78 Million |
|
Symphony Limited
NSE:SYMPHONY
|
$128.85 Million |
|
BASSAC EO 1
F:78Y
|
$128.73 Million |
|
Cruzeiro do Sul Educacional S.A
SA:CSED3
|
$128.71 Million |
|
BUKALAPAK COM TBKPT RP50
F:5E9
|
$128.69 Million |
|
Dongbu Corp
KO:005965
|
$128.65 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Pacific Hospital Supply Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,833,559,000 to 2,942,226,000, a change of 108,667,000 (3.8%).
- Net income of 447,846,000 contributed positively to equity growth.
- Dividend payments of 348,480,000 reduced retained earnings.
- Other comprehensive income decreased equity by 483,771,000.
- Other factors increased equity by 493,072,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$447.85 Million | +15.22% |
| Dividends Paid | NT$348.48 Million | -11.84% |
| Other Comprehensive Income | NT$-483.77 Million | -16.44% |
| Other Changes | NT$493.07 Million | +16.76% |
| Total Change | NT$- | 3.84% |
Book Value vs Market Value Analysis
This analysis compares Pacific Hospital Supply Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.03x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 6.15x to 2.03x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-12-31 | NT$13.40 | NT$82.40 | x |
| 2010-12-31 | NT$16.20 | NT$82.40 | x |
| 2011-12-31 | NT$20.69 | NT$82.40 | x |
| 2012-12-31 | NT$22.51 | NT$82.40 | x |
| 2013-12-31 | NT$23.08 | NT$82.40 | x |
| 2014-12-31 | NT$25.24 | NT$82.40 | x |
| 2015-12-31 | NT$27.69 | NT$82.40 | x |
| 2016-12-31 | NT$30.02 | NT$82.40 | x |
| 2017-12-31 | NT$31.01 | NT$82.40 | x |
| 2018-12-31 | NT$31.69 | NT$82.40 | x |
| 2019-12-31 | NT$34.96 | NT$82.40 | x |
| 2020-12-31 | NT$35.82 | NT$82.40 | x |
| 2021-12-31 | NT$37.07 | NT$82.40 | x |
| 2022-12-31 | NT$37.20 | NT$82.40 | x |
| 2023-12-31 | NT$38.78 | NT$82.40 | x |
| 2024-12-31 | NT$40.53 | NT$82.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Pacific Hospital Supply Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 15.22%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 19.10%
- • Asset Turnover: 0.60x
- • Equity Multiplier: 1.32x
- Recent ROE (15.22%) is above the historical average (15.08%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | -1.16% | -1.12% | 0.78x | 1.33x | NT$-122.27 Million |
| 2010 | 25.50% | 27.55% | 0.76x | 1.22x | NT$209.03 Million |
| 2011 | 21.42% | 24.06% | 0.76x | 1.18x | NT$172.34 Million |
| 2012 | 19.09% | 21.79% | 0.73x | 1.21x | NT$149.25 Million |
| 2013 | 19.13% | 22.29% | 0.71x | 1.20x | NT$153.61 Million |
| 2014 | 17.74% | 21.70% | 0.67x | 1.22x | NT$142.70 Million |
| 2015 | 17.37% | 21.66% | 0.61x | 1.32x | NT$149.08 Million |
| 2016 | 15.19% | 19.69% | 0.51x | 1.52x | NT$113.67 Million |
| 2017 | 10.49% | 13.67% | 0.48x | 1.61x | NT$11.05 Million |
| 2018 | 9.36% | 11.87% | 0.51x | 1.55x | NT$-14.76 Million |
| 2019 | 17.99% | 22.50% | 0.52x | 1.55x | NT$203.94 Million |
| 2020 | 12.58% | 15.14% | 0.55x | 1.51x | NT$67.32 Million |
| 2021 | 14.28% | 19.14% | 0.53x | 1.40x | NT$115.87 Million |
| 2022 | 12.20% | 15.17% | 0.60x | 1.34x | NT$59.73 Million |
| 2023 | 14.85% | 18.14% | 0.62x | 1.33x | NT$137.44 Million |
| 2024 | 15.22% | 19.10% | 0.60x | 1.32x | NT$153.62 Million |
Industry Comparison
This section compares Pacific Hospital Supply Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,744,563,333
- Average return on equity (ROE) among peers: 10.99%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Pacific Hospital Supply Co Ltd (4126) | NT$2.87 Billion | -1.16% | 0.31x | $128.74 Million |
| St.Shine Optical Co Ltd (1565) | $5.39 Billion | 29.48% | 0.60x | $147.19 Million |
| Nang Kuang Pharmaceutical Co Ltd (1752) | $2.19 Billion | 9.94% | 0.50x | $46.91 Million |
| Maxigen Biotech Inc (1783) | $1.14 Billion | 7.68% | 0.11x | $53.63 Million |
| SciVision Biotech Inc (1786) | $1.02 Billion | -2.16% | 0.07x | $107.95 Million |
| Bioteque (4107) | $1.88 Billion | 15.46% | 0.25x | $198.92 Million |
| Chi Sheng Chemical (4111) | $1.22 Billion | 12.60% | 0.47x | $41.85 Million |
| Sunder Biomedical Tech. Co., Ltd. (4115) | $790.45 Million | 1.68% | 0.80x | $2.11K |
| BenQ Medical Technology (4116) | $1.10 Billion | 2.62% | 0.78x | $25.45 Million |
| Unicon Optical Co., Ltd. (4150) | $963.23 Million | 21.57% | 0.59x | $22.68 Million |